(SRPT) Sarepta Therapeutics Renko charts technical analysis
(SRPT) Sarepta Therapeutics Renko charts technical analysis Renko analysis of Sarepta Therapeutics | Buy/Sell Sarepta Therapeutics
Sarepta Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Sarepta Therapeutics is 2927880
| Date | Closing Price | Open | High | Low | Volume |
| 18 Thu Dec 2025 | 20.35 | 21.23 | 21.64 | 20.14 | 1.395 Mn |
| 17 Wed Dec 2025 | 21.14 | 22.36 | 22.49 | 21.06 | 1.461 Mn |
| 16 Tue Dec 2025 | 22.31 | 21.49 | 22.97 | 21.35 | 3.644 Mn |
| 15 Mon Dec 2025 | 21.55 | 21.88 | 22.34 | 20.93 | 3.231 Mn |
| 12 Fri Dec 2025 | 21.53 | 21.72 | 21.74 | 21.18 | 2.009 Mn |
| 11 Thu Dec 2025 | 21.75 | 21.08 | 21.96 | 20.76 | 4.776 Mn |
| 10 Wed Dec 2025 | 22.20 | 22.11 | 22.67 | 21.84 | 3.104 Mn |
| 09 Tue Dec 2025 | 22.17 | 22.46 | 22.85 | 21.85 | 2.222 Mn |
| 08 Mon Dec 2025 | 21.86 | 22.53 | 22.67 | 21.44 | 3.81 Mn |
| 05 Fri Dec 2025 | 22.26 | 22.89 | 22.93 | 21.94 | 2.659 Mn |
Indicators analysis of Sarepta Therapeutics (SRPT)
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Sarepta Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Sarepta Therapeutics in short term but the sell signal is initial and weak.
Sarepta Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Sarepta Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Sarepta Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 21.83 and Sarepta Therapeutics (SRPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sarepta Therapeutics (SRPT) stock. Volume based technical analysis of Sarepta Therapeutics (SRPT) stock is negative.
Sarepta Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Sarepta Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Sarepta Therapeutics in short term but the sell signal is initial and weak.
Sarepta Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Sarepta Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Sarepta Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 21.83 and Sarepta Therapeutics (SRPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sarepta Therapeutics (SRPT) stock. Volume based technical analysis of Sarepta Therapeutics (SRPT) stock is negative.
Sarepta Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

